These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 11031802)

  • 1. Substance abuse and HIV infection.
    Ferrando SJ; Batki SL
    New Dir Ment Health Serv; 2000; (87):57-67. PubMed ID: 11031802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug abuse aspects of HIV/AIDS and other infections.
    AIDS Read; 2001 Feb; 11(2):84. PubMed ID: 11279883
    [No Abstract]   [Full Text] [Related]  

  • 3. Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems.
    Palepu A; Raj A; Horton NJ; Tibbetts N; Meli S; Samet JH
    J Subst Abuse Treat; 2005 Jan; 28(1):3-9. PubMed ID: 15723726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of HIV infection in a general psychiatric outpatient population.
    Beyer JL; Taylor L; Gersing KR; Krishnan KR
    Psychosomatics; 2007; 48(1):31-7. PubMed ID: 17209147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-risk behaviors among a middle class population: a preliminary investigation among adolescent vs. adult substance users.
    Meyers K; Jaeger JL; Valliere VN; Jensen JM; Pettinati HM; Evans BD; Sargiotto P
    NIDA Res Monogr; 1990; 105():351-2. PubMed ID: 1876037
    [No Abstract]   [Full Text] [Related]  

  • 6. Female drug abusers and the context of their HIV transmission risk behaviors.
    Allen K
    NIDA Res Monogr; 1994; 143():48-63. PubMed ID: 8742591
    [No Abstract]   [Full Text] [Related]  

  • 7. Behavioral aspects of HIV care: adherence, depression, substance use, and HIV-transmission behaviors.
    Berg CJ; Michelson SE; Safren SA
    Infect Dis Clin North Am; 2007 Mar; 21(1):181-200, x. PubMed ID: 17502235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
    Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric issues and emergencies in HIV infection.
    Lyketsos CG; Fishman M; Treisman G
    Emerg Med Clin North Am; 1995 Feb; 13(1):163-77. PubMed ID: 7851315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using focus groups in drug abuse and HIV/AIDS research.
    Shedlin MG; Schreiber JM
    NIDA Res Monogr; 1995; 157():136-55. PubMed ID: 8684435
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
    Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A
    HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV risk and history of STDs in MCMI-III psychopathology subgroups of comorbid substance abusers.
    McMahon RC; Malow RM; Devieux J; Rosenberg R; Jennings T
    Am J Drug Alcohol Abuse; 2008; 34(3):329-37. PubMed ID: 18428075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants.
    Disney E; Kidorf M; Kolodner K; King V; Peirce J; Beilenson P; Brooner RK
    J Nerv Ment Dis; 2006 Aug; 194(8):577-83. PubMed ID: 16909065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-assessment interviewing for HIV.
    O'Connell CB
    Physician Assist; 1993 Mar; 17(3):35-6, 41-3. PubMed ID: 10171396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faces of HIV/AIDS and substance abuse in Native American communities.
    Saylors K; Jim N; Plasencia AV; Smith D
    J Psychoactive Drugs; 2005 Sep; 37(3):241-6. PubMed ID: 16295006
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV infection among substance abusers in Thanyarak Institute On Drug Abuse, Thailand, 1987-2002.
    Verachai V; Phutiprawan T; Sawanpanyalert P
    J Med Assoc Thai; 2005 Jan; 88(1):76-9. PubMed ID: 15960222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV prevention protocols: adaptation to evolving trends in drug use.
    Wechsberg WM; Desmond D; Inciardi JA; Leukefeld CG; Cottler LB; Hoffman J
    J Psychoactive Drugs; 1998; 30(3):291-8. PubMed ID: 9798795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric diagnosis in HIV-spectrum disorders.
    Bialer PA; Wallack JJ; Snyder SL
    Psychiatr Med; 1991; 9(3):361-75. PubMed ID: 1924827
    [No Abstract]   [Full Text] [Related]  

  • 19. The effectiveness of psychiatric treatment for HIV-infected patients.
    Lyketsos CG; Fishman M; Hutton H; Cox T; Hobbs S; Spoler C; Hunt W; Driscoll J; Treisman G
    Psychosomatics; 1997; 38(5):423-32. PubMed ID: 9314711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant abuse treatment and HIV.
    Siever MD
    Focus; 1998 Mar; 13(4):4-6. PubMed ID: 11365172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.